Diabetogenic T-cell clones recognize an altered peptide of chromogranin A

Diabetes

Volumn 61, Issue 12, 2012, Pages 3239-3246

  Delong, Thomas ^a   Baker, Rocky L ^a   He, Jing ^a   Barbour, Gene ^a   Bradley, Brenda ^a   Haskins, Kathryn ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; EPITOPE; OLIGOMER; PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; WE14 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CELL CLONE; CELL ISOLATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETOGENESIS; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PANCREAS ISLET CELL; PRIORITY JOURNAL; PROTEIN PROCESSING; TRANSGENIC MOUSE;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; CHROMATOGRAPHY, GEL; CHROMOGRANIN A; FLOW CYTOMETRY; MICE; MICE, INBRED NOD; MICE, TRANSGENIC; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; TRANSGLUTAMINASES;

EID: 84870323723     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db12-0112     Document Type: Article

References (24)

1. Haskins K. Pathogenic T-cell clones in autoimmune diabetes: more lessons from the NOD mouse. Adv Immunol 2005;87:123-162 (Pubitemid 41133493)
2. Stadinski BD, Delong T, Reisdorph N, et al. Chromogranin A is an autoantigen in type 1 diabetes. Nat Immunol 2010;11:225-231
3. Curry WJ, Barkatullah SC, Johansson AN, et al. WE-14, a chromogranin a-derived neuropeptide. Ann N Y Acad Sci 2002;971:311-316 (Pubitemid 35305315)
4. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003;4:140-156 (Pubitemid 36172696)
5. Nikoopour E, Sandrock C, Huszarik K, et al. Cutting edge: vasostatin-1-derived peptide ChgA29-42 is an antigenic epitope of diabetogenic BDC2.5 T cells in nonobese diabetic mice. J Immunol 2011;186:3831-3835
6. Katz JD, Wang B, Haskins K, Benoist C, Mathis D. Following a diabetogenic T cell from genesis through pathogenesis. Cell 1993;74:1089-1100 (Pubitemid 23289465)
7. Pauza ME, Dobbs CM, He J, et al. T-cell receptor transgenic response to an endogenous polymorphic autoantigen determines susceptibility to diabetes. Diabetes 2004;53:978-988 (Pubitemid 38436610)
8. Cantor J, Haskins K. Effector function of diabetogenic CD4 Th1 T cell clones: a central role for TNF-alpha. J Immunol 2005;175:7738-7745 (Pubitemid 41713474)
9. Delong T, Baker RL, Reisdorph N, et al. Islet amyloid polypeptide is a target antigen for diabetogenic CD4+ T cells. Diabetes 2011;60:2325-2330
10. Yoshida K, Martin T, Yamamoto K, et al. Evidence for shared recognition of a peptide ligand by a diverse panel of non-obese diabetic mice-derived, islet-specific, diabetogenic T cell clones. Int Immunol 2002;14:1439-1447 (Pubitemid 36024610)
11. Sollid LM. Molecular basis of celiac disease. Annu Rev Immunol 2000;18:53-81 (Pubitemid 30365374)
12. Folk JE, Finlayson JS. The epsilon-(gamma-glutamyl)lysine crosslink and the catalytic role of transglutaminases. Adv Protein Chem 1977;31:1-133
13. Folk JE. Transglutaminases. Annu Rev Biochem 1980;49:517-531
14. Daniel D, Gill RG, Schloot N, Wegmann D. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol 1995;25:1056-1062
15. Cloos PA, Christgau S. Post-translational modifications of proteins: implications for aging, antigen recognition, and autoimmunity. Biogerontology 2004;5:139-158 (Pubitemid 39004541)
16. Doyle HA, Mamula MJ. Posttranslational modifications of self-antigens. Ann N Y Acad Sci 2005;1050:1-9 (Pubitemid 41129418)
17. Mannering SI, Harrison LC, Williamson NA, et al. The insulin A-chain epitope recognized by human T cells is posttranslationally modified. J Exp Med 2005;202:1191-1197 (Pubitemid 41586950)
18. Griffin M, Casadio R, Bergamini CM. Transglutaminases: nature's biological glues. Biochem J 2002;368:377-396 (Pubitemid 35454517)
19. Su AI, Wiltshire T, Batalov S, et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc Natl Acad Sci USA 2004;101:6062-6067 (Pubitemid 38520528)
20. Bungay PJ, Owen RA, Coutts IC, Griffin M. A role for transglutaminase in glucose-stimulated insulin release from the pancreatic beta-cell. Biochem J 1986;235:269-278 (Pubitemid 16042001)
21. Bernassola F, Federici M, Corazzari M, et al. Role of transglutaminase 2 in glucose tolerance: knockout mice studies and a putative mutation in a MODY patient. FASEB J 2002;16:1371-1378 (Pubitemid 34913309)
22. Weyer C, Bogardus C, Mott DM, Pratley RE. The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. J Clin Invest 1999;104:787-794 (Pubitemid 29536364)
23. Gallwitz B, Kazda C, Kraus P, Nicolay C, Schernthaner G. Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes. Acta Diabetol. 23 August 2011 [Epub ahead of print]
24. Russo L, Marsella C, Nardo G, et al. Transglutaminase 2 transamidation activity during first-phase insulin secretion: natural substrates in INS-1E. Acta Diabetol. 3 March 2012 [Epub ahead of print]